近端胃病变内镜黏膜下剥离术在残胃与全胃中的临床结局
本研究回顾性纳入135例近端胃肿瘤行内镜黏膜下剥离术(ESD)的患者,比较远端胃切除术后残胃与全胃近端病变的整块切除率、完全切除率及并发症率。经1:2倾向性匹配后,残胃与全胃的整块切除率(92% vs 92.0%,P=1.000)和完全切除率(84% vs 88.0%,P=0.723)无显著差异。黏膜下纤维化(OR 5.9,95%CI 1.1-30.7)和黏膜下浸润癌(OR 10.1,95%CI 1.4-74.3)是不完全切除的独立危险因素。
要点
- 残胃与全胃近端病变行ESD的整块切除率和完全切除率无显著差异。
- 黏膜下纤维化和黏膜下浸润癌是不完全切除的独立危险因素。
- ESD可作为近端胃病变的治疗选择,无论是否有远端胃切除史。
核心结论
- ESD是近端胃病变的可行治疗选择,无论患者是否有远端胃切除史。
- 但黏膜下纤维化或黏膜下浸润癌病变的完全切除率下降。
研究设计与样本
- 按是否行远端胃切除分组,经1:2倾向性匹配后比较临床结局。
主要发现
- 残胃与全胃的整块切除率分别为92%(23/25)和92.0%(46/50),P=1.000。
- 残胃与全胃的完全切除率分别为84%(21/25)和88.0%(44/50),P=0.723。
- 多变量分析显示黏膜下纤维化(OR 5.9,95%CI 1.1-30.7)和黏膜下浸润癌(OR 10.1,95%CI 1.4-74.3)是不完全切除的独立危险因素。
临床怎么用
- 对于近端胃病变,无论有无远端胃切除史,均可考虑行ESD。
- 术前应评估黏膜下纤维化和浸润深度,以预测完全切除的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tumors located on the proximal stomach are associated with a longer procedure time and lower en-block resection of endoscopic submucosal dissection (ESD). Additionally, it is more difficult to perform ESD for lesions after distal gastrectomy because of the narrow inner space. We aimed to evaluate the therapeutic outcomes of ESD for lesions on the remnant stomach compared with those on the upper third of the entire stomach. METHODS: A total of 135 patients with a neoplasm located on the proximal stomach who received ESD between Aug 2008 and Dec 2016 were enrolled. We retrospectively reviewed en-bloc resection rate, complete resection rate, and complication rate according to whether distal gastrectomy was performed. Clinical outcomes were compared among the 1:2 propensity-matched groups. RESULTS: Between the remnant stomach and entire stomach, the en-bloc [92% (23/25) and 92.0% (46/50), respectively; P = 1.000] and complete resection [84% (21/25) and 88.0 (44/50), respectively; P = 0.723] rates were not significantly different. In patients with lesions that indicated ESD, there was no significant difference in en-bloc and complete resection rates. In a multivariable analysis, submucosal fibrosis [odds ratio (OR) 5.9, 95% confidence interval (CI) 1.1-30.7] and submucosa invasive cancer (OR 10.1, 95% CI 1.4-74.3) were independent risk factors for incomplete resection. CONCLUSIONS: ESD is a feasible therapeutic option for lesions located on the proximal stomach regardless the operation history of distal gastrectomy. However, the complete resection rate decreases for lesions with submucosal fibrosis or the submucosa invasion.
引用
- Kim SJ, Choi CW, Kang DH, et al. Clinical outcomes of endoscopic submucosal dissection for lesions on the proximal location between remnant and entire stomach. Surg Endosc. 2019. PMID: 31139997. doi:10.1007/s00464-019-06844-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。